Evaluation of Microelectrode-Based High Definition Brain Stimulation in Adults with Parkinsons Disease or Essential Tremor Scheduled for DBS Surgery
Led by Lund University · Updated on 2026-11-03
12
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating a new method called High Definition Brain Stimulation HDBS for patients with Parkinsons disease and Essential Tremor who are scheduled for standard Deep Brain Stimulation DBS surgery. Current treatments, including medications and traditional DBS, have limitations and side effects, so this study aims to test if HDBS can provide effective symptom relief with fewer negative effects. This early feasibility study is the first time HDBS will be tested in humans.
The study uses a specialized device made of tiny, flexible microelectrodes inserted into the brain of awake patients along the same path planned for the permanent DBS electrode. Researchers will stimulate specific groups of these microelectrodes at various depths, gradually increasing intensity to find the best therapeutic effect without causing side effects. The evaluation lasts up to 2.5 hours, after which the device is removed, and the permanent DBS electrode implantation is completed. This approach allows individualized selection of stimulation sites.
Participants will be closely monitored during stimulation, with their motor function, speech, facial expressions, and tremor changes recorded verbally and on video. The study will analyze these responses linked to the stimulation settings to determine effectiveness and side effects. Data will be anonymized. The results will also help surgeons improve permanent DBS electrode placement. Overall, the study could lead to better brain stimulation therapies for neurological disorders.
CONDITIONS
Brief Title
Effects of Microelectrode-based Brain Stimulation in Humans
Research Team
J
Jens Schouenborg, PhD
H
Hjalmar Bjartmarz, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Adult patients with Parkinson's disease or Essential Tremor already scheduled for permanent Deep Brain Stimulation implantation
Ability to fully understand the patient information
Willingness to be awake during the evaluation
Consent to be video recorded during the procedure
You will not qualify if you...
Unwillingness to be awake during the stimulation procedure
Neurosurgeon considers the extended surgery time (up to 2.5 hours) an unacceptable risk
Known history of blood clotting disorders
Known history of bleeding disorders
Age under 18 years
Pregnant or breastfeeding women
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 2.5 hours
Participants undergo insertion of the investigational microelectrode device in the brain while awake. Stimulation is applied to specific microelectrode groups at different brain depths. Responses are monitored and recorded. After evaluation, the device is removed and permanent Deep Brain Stimulation electrode implantation is completed.
Single procedure visit
Follow-up
Duration - 3 to 8 weeks
Researchers compare stimulation mapping results from the investigational device with outcomes from the permanent Deep Brain Stimulation electrode 3 to 8 weeks after surgery to assess accuracy and success.
1 to 2 visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
24-Month Open-Label Study of Home-Based Peroneal Electrical Transcutaneous NeuroModulation Using URIS ITM Device for Parkinsons Disease and Essential Tremor
Evaluating 3-D Tractography Guided Focused Ultrasound for Treating Essential Tremor with Intraoperative MRI Monitoring
Phase 3 Study Evaluating Bemdaneprocel Cell Therapy Compared to Sham Surgery in Adults with Parkinsons Disease
Long-Term International Study of Abbott Deep Brain Stimulation Systems for Movement Disorders Including Parkinsons Disease, Tremor, and Dystonia
Using Advanced Algorithms to Optimize Deep Brain Stimulation for Essential Tremor Treatment
Long-Term Study of MR-Guided Focused Ultrasound Thalamotomy for Medication-Resistant Essential Tremor
Evaluating Safety and Clinical Outcomes Over 3 Years at Sunnybrook Health Sciences Centre
Study of Skin Protein Changes to Identify Risk of Parkinsons in Essential Tremor Patients
Studying How Deep Brain Stimulation Affects Attention, Perception, and Cognition in Parkinsons Disease and Other Movement Disorders
Using Artificial Intelligence to Analyze Language in Neurodegenerative Diseases
A Study of Speech Patterns in Alzheimers, Parkinsons, and Related Conditions
Study of Biological Factors and Brain Compensation in Swallowing Problems in Parkinsons Disease
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Christopher G Goetz, Stanley Fahn, Pablo Martinez-Martin...